Bengaluru-based pharmaceutical firm Sami-Sabinsa Group has been awarded with the best patent portfolio and best trademark portfolio in SME (life science and pharma) at the recently held CII Industrial Intellectual Property Awards.
“These awards are a recognition of the pioneering work accomplished in the IP domain by the Sami-Sabinsa team,” said Dr Muhammed Majeed, founder and chairman, Sami-Sabinsa Group. “With research at the core of everything we do, Sami-Sabinsa continues to develop innovative, patented nutraceutical and cosmeceutical products for our clients globally.”
The firm was founded by Majeed in 1988 and produces nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, and probiotics. Sami-Sabinsa Group has independent research divisions, including natural drugs, phytochemistry, synthetic chemistry, tissue culture, biotechnology, analytical R&D, biological research, microbiology and formulations R&D.